Fingerprint
Dive into the research topics of 'Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis
Xiaojuan Yang, Jiuxia Pang, Na Shen, Fei Yan, Lai Chu Wu, Aref Al-Kali, Mark R. Litzow, Yong Peng, Robert J. Lee, Shujun Liu
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations